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Anemia is a commonly encountered clinical problem in critically ill patients. The etiology of anemia is multifactorial and includes diminished erythropoietin 
activity, poor iron use by the body, and blood loss (both iatrogenic 
and non-iatrogenic) [1]. In various studies, the prevalence of 
anemia at the time of admission into the intensive care unit has 
been reported up to 77%. The incidence of anemia in patients with 
septic shock has not been well established globally. In addition, 
many adult studies in critically ill patients have shown that anemia 
is associated with worse outcomes, due to diminished oxygen 
delivery to the tissues. The impact of anemia on the outcome of 
children with septic shock is not well understood [2,3]. There is a 
paucity of information on the prevalence, severity, and immediate 
outcome of anemic children with septic shock in India. Hence, 
our primary objective was to estimate the prevalence and analyze 
the impact of anemia on morbidity and mortality in children with 
septic shock in a tertiary care hospital.
Transfusion of blood products, especially packed red blood 
cell (PRBC), is an important therapeutic intervention in such 
patients. The outcomes are not always beneficial and one must 
weigh the risk:benefit ratio before transfusion [4]. Many studies 
in heterogeneous groups of critically ill adults showed that 
RBC transfusions are independently associated with increased 
morbidity and mortality [3,5,6]. The data related to this is 
relatively scarce. In 2007, Lacroix et al. provided evidence that 
the lower threshold of Hb 7.0 g/dL was safe for transfusion in 
stabilized critically ill patient population [7]. A similar threshold 
was considered safe for children with sepsis based on a study by 
Karam et al. in 2011 [8]. Hence, the secondary objective of our 
study was to explore the relationship between blood transfusion 
and clinical outcomes in critically ill pediatric patients with septic 
shock.
MATERIALS AND METHODS
This prospective observational single-center study was conducted 
in the pediatric ICU (PICU) of a tertiary care teaching hospital 
in South India. The enrolment period was from July 2013 to 
July 2014. The inclusion criteria were children from 1 month to 
16 years of age admitted to the PICU and diagnosed with septic 
shock. Septic shock was defined as sepsis with cardiovascular 
dysfunction (i.e., hypotension, reliance on vasoactive drug 
administration to maintain a normal blood pressure, or two of the 
following: Prolonged capillary refill, oliguria, metabolic acidosis, 
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or elevated arterial lactate) that persists despite the administration 
of ≥40 mL/kg of isotonic saline in one hour [9].
Patients with cyanotic heart disease, chronic lung disease, 
chronic renal failure, preexisting chronic anemia, and active 
bleeding, and patients undergoing chemotherapy were excluded 
from the study. Patients were followed for either 30 days or 
until hospital discharge or death if these occurred before day 30. 
The study was approved by the institutional ethics committee. 
Informed written consent was obtained from the parent(s)/
guardian(s) of each patient before enrollment. Data related to age, 
gender, Pediatric Risk of Mortality (PRISM III) score, and primary 
and secondary admitting diagnoses were recorded. The PRISM 
III score is based on clinical and laboratory parameters assessed 
during the first 12 h. Hemoglobin (Hb) level on capillary, venous, 
or arterial blood sample was collected within 24 h. Additional 
information was recorded subsequently (duration of inotropes 
and mechanical ventilation, PRBC transfusion, duration of PICU, 
and length of hospital stay). Routine and specific investigations 
including cultures done in all cases were also recorded. Anemia 
was defined according to the WHO nutrition information system 
based on hemoglobin levels at admission - Hb concentration 
<11 g/dl in younger children is described as anemia and severe 
anemia when Hb was lower than 7 g/dl [10]. The children were 
treated as per standard protocol guidelines.
The following categories - anemia (Hb7–11 g/dl), severe 
anemia (<7 g/dl), and non-anemic group (Hb>11 g/dl) were 
created based on Hb at admission for subsequent analysis to 
assess the impact on of severity of anemia on outcome in children 
with septic shock. Similarly, to explore the relationship between 
blood transfusion and clinical outcomes, we compared transfused 
versus non-transfused group.
Indications for RBC transfusion in these children with septic 
shock were persistent shock, metabolic acidosis (BE > −5), 
elevated lactate, or a central venous saturation (ScvO2) of < 70%, 
to optimize hematocrit to 30. The primary outcome was mortality 
at 30 days. The secondary outcome measures were the duration 
of PICU, hospital stay, inotropic support, and ventilation hours.
Sample Size Calculations
For estimating the prevalence of anemia, the confidence level is 
set at 95%, proportion of interest is 60%, and confidence interval 
is 0.05 (upper and lower interval set at 0.15 and 0.05). The 
standard error is set at 0.0255. Using these estimates, the sample 
size for recruitment is set at 132 eligible children. For analyzing 
the outcomes due to anemia and blood transfusion, the estimates 
are the same as above, and the proportion of interest is 50%; 
thus, the sample size calculation is 130. We planned to enroll a 
convenience sample of 150 children.
Statistical Analysis
Data were entered into the Microsoft Excel spreadsheet. SPSS 
software for Windows (version 23.0, Chicago, Inc.) was used 
for all the analyses. Continuous variables were reported using 
mean ± standard deviation for the normally distributed variables 
otherwise median and interquartile range was used. Categorical 
variables were expressed as percentage/proportions and analyzed 
using the Chi-square test. Mann–Whitney U-test was used to 
compare the differences between the anemic and non-anemic 
groups and also between the transfused and non-transfused 
groups. Multivariate logistic regression analysis was used to find 
the association between PRBC transfusion and outcome. All the 
analysis was statistically significant at 5% level (p<0.05).
RESULTS
During the study period, a total of 150 children diagnosed with 
septic shock admitted to our PICU were found to be eligible. 
Baseline characteristics of the study group are summarized in 
Table 1 and Fig. 1 and 2.
The median age of our children was 11 months (IQR 4, 37). 
The male:female ratio was 1.1:1. 66% of the children required 
invasive ventilation. The median duration of inotropic requirement 
in children with septic shock was 48 h (4, 96). The overall 
mortality in children with 90% of cases was community-acquired 
sepsis and only 8% were secondary to nosocomial infections 
septic shock was 16% (Table 1).
The number of children with culture-positive sepsis was 36%. 
32% children had blood culture positive sepsis and 14% had other 
body fluid/site samples such as endotracheal tube secretions, 
urine, cerebrospinal fluid, ascitic fluid, stool, and pleural fluid 
positive for organism growth. 10% have cultures positive in both 
blood and other sites.
Of 150 children with septic shock, 95 were found to be 
anemic at admission. Among them, severe anemia (Hb<7 g/dl) 
was detected in 19% of these cases with a higher PRISM III score 
9 (3.7, 13.25). Majority of the anemic children were found to be 
<1 year of age (p<0.05). 15 children (17%) died in anemic group, 
Table 1: Baseline characteristics of children with septic shock: 
(n=150)
Age, months, median (IQR) 11 (4,37)
Male:female 1.1:1
PRISM III score, median (IQR) 7 (3,12)
Catecholamine resistant shock% (n) 40 (60)
Prevalence of anemia % (n) 63 (95)
Prevalence of severe anemia% (n) 19 (20)
Admission Hb ( g/dl), mean (SD) 9.9 (2.5)
Culture positive sepsis (%) 36
Number of children requiring mechanical 
ventilation (%)
99 (66)
Hours of mechanical ventilation median (IQR)  96 (60,192)
Hours inotropic duration median (IQR) 48 (4,96)
Length of hospital stay, median (IQR) 9 (4,13)
Length of ICU stay, median (IQR) 5 (3,8)
Mortality rate (%) 16 (24)
IQR: Interquartile range, ICU: Intensive care unit, SD: Standard deviation
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and only 4 were found to be severely anemic. Length of PICU 
and hospital stay, inotropic requirement, and hours of ventilation 
did not vary with the severity of anemia (Table 2). There was 
no statistically significant difference in the ICU mortality rates 
among different Hb% groups (p – 0.9).
Subgroup Analysis: PRBC Transfusion and Outcome in 
Children with Septic Shock
In our study, out of 150 children with septic shock, 42 (28%) 
received blood transfusion. Among 42 children, 20 were 
severely anemic at admission, hence, received transfusion and 
the remaining 22 children were transfused in view of ongoing 
hemodynamic instability to optimize hematocrit to 30. We 
compared the outcome between the transfused and non transfused 
group to explore the impact of transfusion on outcome. We 
noticed that the children requiring transfusion had a significantly 
longer duration of inotropic requirement (p=0.025). The length 
of PICU stay and hours of ventilation did not vary between the 
two groups. The transfused group had 24% mortality. The PRISM 
III score was higher in the transfused group but not statistically 
significant. On multivariate analysis, the transfused group had 
a higher PRISM III score ([odds ratio [OR] - 1.13 [1.05–1.205] 
p<0.01). Similarly, the relative odds of mortality after adjusting 
for the severity of illness were higher as compared to the non-
transfused group ([OR - 2.168] p - 0.08] (Table 3).
DISCUSSION
Critically ill pediatric patients have a high incidence of anemia 
at the time of admission. This was observed in our study as the 
prevalence of anemia was 63% at admission in our cohort of 
children with septic shock [11].
Critically ill patients will develop anemia at some point in 
their intensive care unit course. Anemia is associated with worse 
outcomes in critically ill pediatric patients, due to diminished 
oxygen delivery to the tissues [12]. A global review on pediatric 
septic shock reported an overall mortality rate up to 23% shock, 
but studies correlating anemia and outcomes in children with 
septic shock were very few [13]. We found anemia is common in 
the PICU, but lower Hb concentrations were not associated with 
higher mortality and poorer outcomes.
Many studies in critically ill adults in medical and surgical 
ICU revealed poor patient outcomes among the anemic, but only 
few pediatric studies showed clinical outcomes of anemia in 
critically ill children. Worse outcomes including higher mortality, 
extubation failures, and longer length of ICU stay were observed 
in anemic patients in various cohorts of critically ill adults across 
regions [5,14,15]. Severe anemia was associated with higher 
mortality in a Nigerian study of critically ill children [16]. Our study 
reflected no significant risk of death with severe anemia. There 
were no worse outcomes in terms of duration of ICU stay, hours 
of invasive ventilation, and inotrope duration among those with 
anemia. The possible explanation could be as majority of the children 
were chronically anemic due to nutritional deficiency, so their 
adaptive mechanisms might have helped to compensate during their 
illness [17]. The results of our study did not support the hypothesis 
that anemia is associated with worse outcomes. Studies in children 
have supported the hypothesis that blood transfusion is associated 
with worse outcomes in critically ill patients. The rationale is based on 
the concept that blood transfusion tends to increase oxygen delivery 
to the tissues but as no role on tissue consumption. These factors 
are critical in conditions such as septic shock and acute respiratory 
distress syndrome. Thus, the benefit may not be as significant as 
compared to the varied risks due to transfusion [18].
A review of three key studies done in three different population 
groups (critically ill adults, children, and neonates) all favored 
“restrictive transfusion strategies” that showed better clinical 
outcomes among those who were transfused at a lower Hb 
threshold than those who were more “liberally” transfused [19]. 
Karam et al. showed similar results in children with sepsis where 
a Hb level of 7 g/dl was not associated with worse outcomes and 
considered a safe threshold for transfusion in stabilized children 
with sepsis [8].
Figure 1: Distribution of children with septic shock based on 
hemoglobin (Hb) levels (Hb-g/dl)
Figure 2: The percentage distribution of the primary diagnosis/
system involved at admission in children with septic shock
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Our data were analyzed for clinical outcomes in the transfused 
and non-transfused groups. We observed a higher mortality rate 
among transfused but were not statistically significant [p=0.08]. 
A large retrospective study in critically ill children found PRBC 
transfusion to be an independent risk factor for mortality after 
adjusting for severity of illness [20]. One of the reasons for higher 
mortality in our study population could be because those who 
were transfused had more severe illness. Inotrope requirement was 
significantly longer among transfused children and supported the 
results of Kneyber et al. [4]. The probable reason for this could 
be as transfused children were sicker as reflected by the higher 
PRISM score. However, there was no significant difference in ICU 
stay and duration of ventilator requirement among the two groups. 
Other studies showed significantly worse outcomes with regard to 
all the above variables among those transfused [3,5,21]. We cannot 
conclude that PRBC transfusion is responsible for worse outcomes. 
Further, research and multicentric studies are required to evaluate 
the risk factors for mortality in children with septic shock.
Limitations of the Study
Anemia is a widespread public health problem in India which 
affects children. To the best of our knowledge, our study is the 
largest to date investigating the impact of anemia and possible 
risks of blood transfusion in pediatric intensive care patients in 
our country.
However, some limitations should be considered. First, our 
analysis is single center in nature, and our results are only hypothesis-
generating study. A larger sample size is required to generalize the 
prevalence of anemia in pediatric patients with septic shock. Second, 
the multivariable analysis does not take into account unmeasured 
variables and cannot establish a cause-effect relation between PRBC 
transfusion and outcome. The confounding effect of unmeasured 
variables cannot be excluded. Nevertheless, many relevant variables 
were considered. Third, clinical outcomes of patients transfused at 
lower pretransfusion levels of hemoglobin were not assessed. Finally, 
the results of our study may not be extrapolated to patients with other 
types of shock case, such as cardiogenic or dengue shock.
CONCLUSION
Anemia is common in children with septic shock and is not a risk 
factor for mortality or morbidity. PRBC transfusion is associated 
with higher mortality. Conclusions on outcomes with regard to 
blood transfusion need further research. Our data should be regarded 
as being hypothesis generating and randomized controlled studies 
are warranted to reassess transfusion practice in the ICU.
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Table 2: Comparing clinical outcomes based on severity of anemia at admission and outcomes (Severe anemia [<7 g/dl], Moderate and mild 
[7–11 g/dl], No anemia-> 11g/dl])
Parameter <7 g/dl 7–11 g/dl >11 g/dl p value
Age, months, median (IQR) 6 (2,20) 10 (3,23) 12.5 
(5,79.5)
0.049*
Male:female 1:1 1:1 0.8:1 0.868
Prism score, median (IQR) 9 (3.7,13.25) 6 (2,11) 8 (4,15) 0.16
ICU mortality rate (%) 20 16.8 16 0.9
Multiorgan dysfunction % (n) 63 (60) 63 (60) 70 (39) 0.8
Hospital length of stay, median (IQR) 9 (4.7,14.2) 9 (3.5,12) 9.5 (4,12.8) 0.5
ICU length of stay, median (IQR) 7 (4,8.7) 5 (3,7) 6 (3,9) 0.3
Hours of ventilation, mean (SD) 133 (91) 12 (92) 150 (123) 0.7
Hours of inotropic requirement, median (IQR) 72 (5,108) 48 (2,80) 48 (4,96) 0.4
*p value<0.05 is statistically significant. IQR: Interquartile range, ICU: Intensive care unit, SD: Standard deviation
Table 3: Characteristics and outcomes between the transfused and those non-transfused
Parameter Transfusion 
n - 42
No 
Transfusion 
n - 108
p value Adjusted analysis 
OR (95% CI) 
p-value
Age, month, median (IQR ) 9 (4,30) 11.5 (3,46.5) 0.47 -
Male (%) 0.8:1 1:1 0.6 -
ICU LOS, median (IQR ) 6 (3,9) 5 (3,8) 0.3 -
Hours of ventilation, mean (+ SD) 141 (98) 131 (107) 0.3 -
PRISM score median (IQR ) 9 (3.5,16.5) 6 (3,11) 0.096 1.13 (1.05-1.205) 
p value <0.01*
Hours of inotropic requirement, median (IQR) 72 (6,120) 48 (3,72) 0.025*
ICU mortality rate (%) 10 (24%) 14 (13%) 0.17 2.16 (0.9–5.1) p-0.08
*p value<0.05 is statistically significant. IQR: Interquartile range, ICU: Intensive care unit, SD: Standard deviation, OR: Odds ratio, CI: Confidence interval
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